𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Inflammatory mediators in chronic inflammatory bowel diseases

✍ Scribed by Groß, V. ;Andus, T. ;Leser, H. -G. ;Roth, M. ;Schölmerich, J.

Publisher
Springer-Verlag
Year
1991
Tongue
English
Weight
887 KB
Volume
69
Category
Article
ISSN
1432-1440

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lymphoma in inflammatory bowel disease
Lymphoma in inflammatory bowel disease
✍ Adrian J. Greenstein; Gerard E. Mullin; James A. Strauchen; Tomas Heimann; Henry 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 481 KB 👁 1 views
MicroRNAs in inflammatory bowel disease
MicroRNAs in inflammatory bowel disease
✍ Joel R. Pekow; John H. Kwon 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 1 views

MicroRNAs (miRNAs) are small, noncoding RNAs that regulate gene and protein expression. miRNAs are critical to a normal immune response and have altered expression in multiple immune-mediated disorders. This emerging role of miRNAs in the pathogenesis of multiple disease states has led to investigat

Polyunsaturated fatty acids, inflammator
Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases
✍ Philip C. Calder 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 616 KB

## Abstract With regard to inflammatory processes, the main fatty acids of interest are the n‐6 PUFA arachidonic acid (AA), which is the precursor of inflammatory eicosanoids like prostaglandin E~2~ and leukotriene B~4~, and the n‐3 PUFAs eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).